Replies to post #160 on Eloxx Pharmaceuticals Inc (ELOX)

[Tails]

At a nickel this is crazy. If the trials that are now in cohort 3 are successful then this will move much higher.
To my knowledge there is only one other drug in human trials that addresses the P53.

Looks like a nice risk reward to me.